VRS
CPRX

Virginia Retirement Systems’s Catalyst Pharmaceutical CPRX Stock Holding History

Virginia Retirement Systems’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$901K Buy
38,600
+900
+2% +$20K 0.01% 623
2025
Q3 		$743K Buy
37,700
+4,500
+14% +$92.5K ﹤0.01% 672
2025
Q2 		$720K Buy
33,200
+19,400
+141% +$458K 0.01% 667
2025
Q1 		$335K Buy
+13,800
New +$311K ﹤0.01% 860
2023
Q3 		$1.5M Buy
128,000
+60,700
+90% +$812K 0.01% 404
2023
Q2 		$905K Buy
67,300
+22,700
+51% +$327K 0.01% 578
2023
Q1 		$739K Buy
44,600
+12,500
+39% +$206K 0.01% 625
2022
Q4 		$597K Sell
32,100
-27,700
-46% -$426K 0.01% 781
2022
Q3 		$767K Buy
+59,800
New +$709K 0.01% 666
2022
Q1 		$1.4M Buy
168,700
+88,500
+110% +$626K 0.01% 530
2021
Q4 		$543 Sell
80,200
-12,400
-13% -$81.5K ﹤0.01% 831
2021
Q3 		$491K Sell
92,600
-1,500
-2% -$8.2K 0.01% 794
2021
Q2 		$541K Buy
94,100
+26,500
+39% +$137K 0.01% 813
2021
Q1 		$312K Sell
67,600
-3,000
-4% -$11.9K ﹤0.01% 983
2020
Q4 		$236K Buy
70,600
+16,500
+30% +$55.4K ﹤0.01% 1028
2020
Q3 		$161K Sell
54,100
-15,000
-22% -$58.7K ﹤0.01% 1045
2020
Q2 		$319K Buy
69,100
+41,400
+149% +$186K ﹤0.01% 935
2020
Q1 		$107K Sell
27,700
-600
-2% -$2.46K ﹤0.01% 1047
2019
Q4 		$106K Sell
28,300
-7,000
-20% -$32.7K ﹤0.01% 1113
2019
Q3 		$187K Buy
+35,300
New +$188K ﹤0.01% 1079

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virginia Retirement Systems's CPRX Position: Q4 2025 in Review

Virginia Retirement Systems increased its Catalyst Pharmaceutical (CPRX) stake by 2.4% in Q4 2025, buying an estimated $20K and bringing the position to 38,600 shares worth $901K. The position accounts for 0.01% of the portfolio, ranked #623.

Virginia Retirement Systems first reported a position in CPRX in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.5M in Q3 2023. 373 funds tracked by Wall St. Rank hold CPRX as of Q4 2025.

  • Virginia Retirement Systems held 38,600 shares of Catalyst Pharmaceutical worth $901K as of Q4 2025.
  • Virginia Retirement Systems bought 900 Catalyst Pharmaceutical shares in Q4 2025, an estimated $20K.
  • Catalyst Pharmaceutical made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #623 holding.
  • Virginia Retirement Systems first reported a position in Catalyst Pharmaceutical in Q3 2019 and has held it in 20 quarters since.
  • Virginia Retirement Systems's Catalyst Pharmaceutical position peaked at $1.5M in Q3 2023.
  • 373 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.